$0.879
-0.041 (-4.69%)At close
WALD News
WALD Events
Waldencast Files Form 15 to Terminate Registration
Waldencast announced that it has filed a Form 15 with the SEC to terminate the registration of its Class A ordinary shares and its redeemable warrants under the Exchange Act and to suspend the company's reporting obligations under the Exchange Act. Upon filing of the Form 15, the company's obligation to file periodic and current reports with the SEC is suspended immediately. The termination of registration is expected to become effective 90 days after the filing of the Form 15 or such shorter period as the SEC may determine. As previously announced, as of October 5, the company quoted its Class A ordinary shares and warrants on the Pink Limited market of the OTC Markets Group under the tickers MLKMF and MLKWF, respectively.
Waldencast Files Form 25 with SEC to Deregister Shares
Waldencast has filed a Form 25 with the SEC to remove its Class A ordinary shares, par value $0.0001 per share, and its redeemable warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share, from listing on Nasdaq and to deregister such securities under the Securities Exchange Act. As a result, Waldencast expects that the last trading day of its Class A Ordinary Shares and Warrants on Nasdaq will be on or about October 2. The company intends to file a Form 15 with the SEC on or about October 5 to suspend the company's reporting obligations. The Section 12(b) deregistration is expected to become effective 90 days after the Form 25 filing. The company reserves the right to withdraw or postpone the above filings prior to their effectiveness.
Waldencast Announces Voluntary Delisting from Nasdaq
Waldencast announced that it has notified the Nasdaq Stock Market of its decision to voluntarily delist its Class A ordinary shares and its redeemable warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share, from Nasdaq and to deregister such securities under Section 12(b) of the Securities Exchange Act of 1934, as amended. Company expects to file a Form 25 with the SEC on or about September 24, 2026; delisting expected to become effective on or about October 4, 2026, with the last day of trading on Nasdaq expected to be October 2, 2026. Following completion of the sale of Obagi Medical, Waldencast is a single-brand company; shareholders will be asked at an Extraordinary General Meeting to approve renaming the company Milk Makeup plc. If approved, the company intends to seek to have its Class A Ordinary Shares quoted in an over-the-counter market under a new ticker symbol "MLKM".
Middle East Violence Escalation Weighs on Markets, Tech Stocks Under Pressure
Macro narratives of re-escalation of violence in the Middle East, surging oil prices, and rising bond yields continued to weigh on sentiment, sending major averages down for the third consecutive session. Once again, Energy and defensively oriented Utilities and Health care sectors softened the brunt of impact on the benchmark, though Tech, Basic Materials, Industrials, and Cyclicals paced the prevailing bearish bias. In Tech, Software stocks joined the AI CapEx build out areas of the market - semiconductors, memory, hardware, and equipment - with outsized losses. Applewas a notable counterweight however, gaining nearly 3% on the day.In the opening hour of the evening session, index futures are trading little changed - S&P e-minis are at 7,643 and Nasdaq 100 is just north of 29,100. In commodities, WTI crude oil crossed the upside of $90 per barrel, boosted by more bellicose rhetoric from President Trump regarding his intentions to continue bombing Iran if IRGC retaliates against the latest round of US strikes. Precious metals also remain under pressure, as rising dollar from growing expectations of higher short-term rates sent Gold below $4,370 per ounce.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -GitLabup 15.9%Sportsman's Warehouseup 7.5%Dell Technologiesup 6.7%ALSO HIGHER -Waldencastup 9.6% after insider buyLineageup 1.8% after insider buyDOWN AFTER EARNINGS -MongoDBdown 12.9%Credo Technology Groupdown 9.2%Palo Alto Networksdown 1.8%
Waldencast Receives FDA Approval for Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
Waldencast announced that the U.S. Food and Drug Administration has approved Obagi saypha ChIQ injectable hyaluronic acid gel, the latest addition to the Obagi injectable portfolio under the Obagi Medical brand. Developed by Croma-Pharma GmbH, the dermal filler is indicated for cheek augmentation and the correction of midface contour deficiencies in patients over the age of 21. "Obagi saypha ChIQ is a meaningful addition to our integrated aesthetic portfolio - giving practitioners and patients more ways to achieve end-to-end skin transformation with predictable, measurable outcomes, and bringing us closer to our vision of building the world's leading dermatological megabrand," said Michel Brousset, co-founder and CEO of Waldencast.
Related articles
- International Stocks vs US Stocks in 2026: How the Strong Dollar and Valuations Change the CaseInternational stocks vs US stocks in 2026: how the strong dollar, valuation gaps, Fed hikes and concentration risk shape a smarter global allocation plan now.
- Defensive Stocks in 2026: Is the Rush Into Staples and Healthcare Already Overcrowded?Investors are piling into defensive stocks as tech slides. See why staples and healthcare surged, why valuations look stretched, and how to avoid overpaying.
- Defense Stocks in 2026: How Midterms, the Iran War and a Stalled Budget Shape the OutlookDefense stocks fell after the 2026 midterms. Learn how the Iran war, the $1.5T budget request and the December 11 funding deadline shape the sector outlook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.